Peter Rossing

Academic / Other · 8 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Chronic Kidney Disease(CKD)	Phase 4	2025-06-20
Recruiting	Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study Cardiovascular Autonomic Neuropathy, Type 2 Diabetes, Diabetic Neuropathies	Phase 2	2025-05-02
Completed	PeRsOnalising Treatment Of Diabetic Nephropathy: Diabetes Mellitus, Type 1, Diabetes Complications, Diabetic Nephropathies	—	2016-04-01
Completed	Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes Type 2 Diabetes, Diabetic Nephropathy	Phase 4	2015-08-01
Completed	Microalbuminuria and Allopurinol in Type 1 Diabetes Type 1 Diabetes, Diabetic Nephropathy	Phase 4	2014-09-01
Completed	Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopa Diabetic Nephropathy, Diabetic Retinopathy	Phase 2 / Phase 3	2014-03-01
Completed	Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes Type 2 Diabetes	Phase 4	2012-08-01
Completed	Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy Cardiovascular Disease, Diabetic Nephropathy	Phase 4	2010-04-01